5[4]Coudron PE, Molaond ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Mirobiol, 2000, 38: 1791-1796.
6[12]Aralaw AY, Shibata N, Shibayama K, et al. Convenient test for screening metallo β-lactamases producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38: 40-43.
7Bingen EH, Desjardins P, Arlet G,et al. Molecular epidemiology of plasmid spread among extended broad-spectrum-β-lac-tamase-producing Klebsiella pneumoniae isolates in a pediatric hospital[J]. J Clin Microbiol, 1993, 31: 179.
8National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests approved standard [S]. Seventh edition. NCCLS M100-S10(M7), January 2000.
9Patterson JE, Hardin TC, Kelly CA, et al. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae[J]. Infect Control Hosp Epidemiol, 2000, 21: 455-458.
10Schiappa DA, Hayden MK, Matushek MG, et al. Cef-tazidime-resistant Klebsiella pneumoniae and Escherichia coli blood stream infection: a case-control and molecular epidemiologic investigation[J]. J Infect Dis, 1996, 174: 529-536.
6E1 Moussaoui R, Roede BM, Speelman P, et al. Short- course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of dou- ble-blinde studies[J]. Thorax, 2008,63 (5) : 415.
7Global Initiative for Chronic Obstructive Pulmonary Dis- ease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease[EB/ OL]. http ://www.Goldcopd.com/, 2006-11-19.2009-12.
8Goto H,Takeda H. Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics [ J ]. Jpn J Antibiot ,2008,61 (4) :209 - 210.
